Tuesday, June 15
12:45–1:45 pm EDT
Novartis’ Commitment to Targeted Radioligands in Oncology
Sponsored by Advanced Accelerator Applications, A Novartis Company
- Stephen Moran, PhD, Global Program Head, Global Drug-Development, Advanced Accelerator Applications, a Novartis company
Updates on Novartis’ commitment to research in targeted radioligands and the scientific rationale for patients with cancer
Biograph Vision Quadra First Impressions – A quantum leap in PET/CT imaging
Sponsored by Siemens Healthineers
- Prof. Dr. Med. Axel Rominger, Director of the Department of Nuclear Medicine, Insel Gruppe AG
- Katherina Swystun, Global PET/CT Product Marketing Manager, Siemens Healthineers Molecular Imaging
During this event, Prof. Axel Rominger, the director of the department of nuclear medicine at Switzerland’s Inselspital, Bern University Hospital, will share his first impressions and experiences, as the first worldwide user of the next generation whole-body PET/CT scanner, Biograph Vision Quadra1. Additionally, we will highlight how Biograph Vision Quadra combines the best of both worlds: an extended axial PET field of view (FoV) with industry-leading detector technology, to expand the boundaries of research and reshaped clinical outcomes.
1 Biograph Vision Quadra is not commercially available in all countries. Its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.